FDA approves new drug to treat Alzheimer’s disease - ConsumerAffairs

The U.S. Food and Drug Administration (FDA) has approved a news drug, Kisunla (donanemab-azbt), as a treatment for Alzheimer’s disease. The drug, administe ... Read More

FDA approves new drug for Alzheimer’s disease: ‘Meaningful results’

The U.S. Food and Drug Administration (FDA) has approved a new medication for people with Alzheimer’s disease. Eli Lilly’s Kisunla (donanemab) is a once-monthly injection intended for adults ... Read More

FDA Approves a Second Alzheimer's Drug That Can Modestly Slow Disease

WASHINGTON (AP) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory ... Read More

FDA approves Aduhelm, first new drug for Alzheimer's in 20 years ...

FDA approves first new Alzheimer's drug in nearly two decades, raising hopes despite skepticism 04:09 The need for new drugs to treat the disease is "urgent," Dr. Cavazzoni said. Read More

FDA Approves Biogen's Aducanumab As First New Alzheimer's Drug In ...

The FDA approved the first new drug for Alzheimer's disease in nearly 20 years Monday, even though the decision to greenlight Biogen's new drug has been fraught with controversy. Read More

FDA Approves New Alzheimer's Drug - People.com

FDA Approves Alzheimer's Drug That Promises to Slow Cognitive Decline Early in the Disease U.K. TV Host Fiona Phillips Reveals Alzheimer’s Diagnosis After Believing Symptoms Were Menopause-Related ... Read More

New Alzheimer’s drug is 1st of its kind to be FDA approved

It's the first drug proven to slow the progression of Alzheimer’s disease. In a major development for patients and the biotechnology industry, the U.S. Food and Drug Administration approved the ... Read More

FDA approves new drug to treat Alzheimer's disease - UPI.com

A new drug to treat Alzheimer's disease was approved by the U.S. Food and Drug Administration on Tuesday.. In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines ... Read More

FDA approves new drug Leqembi to treat early Alzheimer’s disease

The FDA has approved the new Alzheimer’s disease drug Leqembi (lecanemab-irmb) for clinical use in patients with early disease. MCKNIGHT’S LONG-TERM CARE NEWS MCKNIGHT’S SENIOR LIVING ... Read More